Clinical Trial Update: Safety of Transplantation of CRISPR CCR5 Modified CD34+ Cells in HIV-infected Subjects With Hematological Malignances [NA]

View source ↗

Summary

This clinical trial update discusses the safety of transplanting CRISPR CCR5-modified CD34+ cells in HIV-1 infected patients with hematologic malignancies. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hematologic Malignancy

Drugs mentioned

• CRISPR CCR5-modified CD34+ cells

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: HIV-1-infection | NA | Status: UNKNOWN